17,932 Shares in Astrana Health, Inc. $ASTH Bought by Great Lakes Advisors LLC

Great Lakes Advisors LLC purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 17,932 shares of the company’s stock, valued at approximately $832,000.

Several other large investors also recently bought and sold shares of ASTH. Diamond Hill Capital Management LLC Investment Advisor acquired a new stake in shares of Astrana Health during the second quarter worth about $22,088,000. Bank of New York Mellon Corp purchased a new stake in shares of Astrana Health in the 2nd quarter valued at about $10,902,000. Bank of America Corp DE boosted its position in shares of Astrana Health by 13.3% in the 1st quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock valued at $14,092,000 after purchasing an additional 67,628 shares during the period. Edgestream Partners L.P. boosted its position in shares of Astrana Health by 68.3% in the 1st quarter. Edgestream Partners L.P. now owns 27,616 shares of the company’s stock valued at $677,000 after purchasing an additional 11,209 shares during the period. Finally, California State Teachers Retirement System grew its stake in Astrana Health by 24.5% during the 1st quarter. California State Teachers Retirement System now owns 51,371 shares of the company’s stock worth $1,260,000 after buying an additional 10,102 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of ASTH stock opened at $39.35 on Friday. The stock’s 50-day moving average price is $41.39 and its 200 day moving average price is $33.39. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 1.05. The stock has a market capitalization of $2.19 billion, a PE ratio of 47.99 and a beta of 0.87. Astrana Health, Inc. has a 52-week low of $18.08 and a 52-week high of $51.60.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.46. The company had revenue of $972.52 million for the quarter, compared to the consensus estimate of $985.62 million. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%.The company’s revenue was up 48.5% on a year-over-year basis. During the same period last year, the business posted $0.19 EPS. As a group, equities research analysts forecast that Astrana Health, Inc. will post 1.31 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. BTIG Research lifted their price target on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Weiss Ratings raised Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 1st. Barclays raised their target price on shares of Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Truist Financial upped their price target on shares of Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Finally, TD Cowen upped their price target on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Astrana Health has an average rating of “Moderate Buy” and a consensus price target of $49.43.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.